This announcement is a separate document:
荣昌生物制药(烟台)股份有限公司关于公司2024年度“提质增效重回报”行动方案的半年度评估报告
Semi-annual evaluation report on the company's "Improving Quality and Efficiency, Returning to Profit" action plan for 2024 of Remegen Pharmaceutical (Yantai) Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.